ENGLEWOOD, Colo., Sept. 3, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced order growth for July and August 2020. Aggregate orders in July and August were 83% above the prior year July and August aggregate […]

– Revenue increased 87% year over year to $19.3 million – Orders increased 37% – Net income of $3.0 million; Diluted EPS $0.09 – Adjusted EBITDA increased 69% to $4.8 million ENGLEWOOD, Colo., July 28, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain […]

ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today the pricing of its previously announced underwritten public offering of an aggregate of 2,500,000 shares of its common stock at a public […]

ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q2 and the full-year 2020. Orders in the second quarter were 37% above the number […]

ENGLEWOOD, Colo., May 18, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has introduced a full catalog of physical therapy products for distribution through its US sales force. Thomas Sandgaard, CEO said: […]

– Revenue increased 66% year over year to $15.2 million – Orders increased 126% – Net income of $2.9 million; Diluted EPS $0.09 – Adjusted EBITDA increased 23% to $3.0 million ENGLEWOOD, Colo., April 28, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain […]

ENGLEWOOD, Colo., April 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 and the full year 2020. Orders in the first quarter were 126% above the number […]

ENGLEWOOD, Colo., Feb. 27, 2020 /PRNewswire/ — 2019 Full Year Revenue increased 42% year over year to $45.5 million Net income $9.5 million; Diluted EPS $0.28 2019 Revenue, net income and Adjusted EBITDA are the highest in Company history Adjusted EBITDA increased 11% to $12.1M 2019 Fourth Quarter Revenue increased 52% year over year to $14.2 million Orders increased 129% Net income […]

ENGLEWOOD, Colo., Jan. 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that  it has signed an addendum to its corporate headquarters building lease expanding the footprint to 86,000 square feet, a 36% increase. Thomas […]